AAAAAA

   
Results: 1-10 |
Results: 10
SOLUBLE CD44 V5 AND V6 IN SERUM OF PATIENTS WITH BREAST-CANCER - CORRELATION WITH EXPRESSION OF CD44 V5 AND V6 VARIANTS IN PRIMARY TUMORS AND LOCATION OF DISTANT METASTASIS
Authors: LACKNER C MOSER R BAUERNHOFER T WILDERSTRUSCHNIG M SAMONIGG H BERGHOLD A ZATLOUKAL K
Citation: C. Lackner et al., SOLUBLE CD44 V5 AND V6 IN SERUM OF PATIENTS WITH BREAST-CANCER - CORRELATION WITH EXPRESSION OF CD44 V5 AND V6 VARIANTS IN PRIMARY TUMORS AND LOCATION OF DISTANT METASTASIS, Breast cancer research and treatment, 47(1), 1998, pp. 29-40
SEQUENTIAL TREATMENT OF RECURRENT MESENTERIC DESMOID TUMOR
Authors: BAUERNHOFER T STOGER H SCHMID M SMOLA M GURTLLACKNER B HOFLER G RANNER G REISINGER E SAMONIGG H
Citation: T. Bauernhofer et al., SEQUENTIAL TREATMENT OF RECURRENT MESENTERIC DESMOID TUMOR, Cancer, 77(6), 1996, pp. 1061-1065
IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIMEOF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
Authors: SAMONIGG H WILDERSTRUSCHNIG M KUSS I PLOT R STOGER H SCHMID M BAUERNHOFER T TIRAN A HAVELEC L LOIBNER H
Citation: H. Samonigg et al., IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIMEOF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL, European journal of cancer, 31A, 1995, pp. 45-45
TREATMENT RESULTS IN MALES WITH BREAST-CANCER
Authors: PAKISCH B STOEGER H POSCHAUKO H SAMONIGG H BAUERNHOFER T POJER E LEITNER H STUECKLSCHWEIGER G PEICHL KH QUEHENBERGER F HACKL A
Citation: B. Pakisch et al., TREATMENT RESULTS IN MALES WITH BREAST-CANCER, European radiology, 5(2), 1995, pp. 172-175
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY
Authors: LUDWIG H SUNDAL E PECHERSTORFER M LEITGEB C BAUERNHOFER T BEINHAUER A SAMONIGG H KAPPELER AW FRITZ E
Citation: H. Ludwig et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE CORRECTION OF CANCER-ASSOCIATED ANEMIA WITH AND WITHOUT CONCOMITANT CYTOTOXIC CHEMOTHERAPY, Cancer, 76(11), 1995, pp. 2319-2329
A PHASE-I II STUDY OF 4'-O-TETRAHYDROPYRANYL-DOXORUBICIN, 5-FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER PATIENTS/
Authors: STOGER H BAUERNHOFER T SCHMID M PLONER F MOSER R DERSTVENSCHEG E STEINDORFER P WILDERSTRUSCHNIG M KUSS I SAMONIGG H
Citation: H. Stoger et al., A PHASE-I II STUDY OF 4'-O-TETRAHYDROPYRANYL-DOXORUBICIN, 5-FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER PATIENTS/, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 174-178
WEEKLY 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN COMBINATION WITH EPIDOXORUBICIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: STOGER H BAUERNHOFER T KASPAREK AK SCHMID M MOSER R PLONER F DERSTVENSCHEG E KUSS I WILDERSTRUSCHNIG M STEINDORFER P ROSANELLI G SAMONIGG H
Citation: H. Stoger et al., WEEKLY 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN COMBINATION WITH EPIDOXORUBICIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 75-78
CANCER OF THE MALE BREAST - A REPORT OF 3 0 PATIENTS
Authors: STOGER H BAUERNHOFER T MOSER R DERSTVENSCHEG E SCHMID M PLONER F PAKISCH B WILDERSTRUSCHNIG M HAAS J STEINDORFER P SAMONIGG H
Citation: H. Stoger et al., CANCER OF THE MALE BREAST - A REPORT OF 3 0 PATIENTS, Wiener Klinische Wochenschrift, 106(18), 1994, pp. 575-580
A PHASE-II TRIAL OF WEEKLY HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH EPIRUBICIN AS SALVAGE CHEMOTHERAPY IN ADVANCED BREAST-CANCER
Authors: STOGER H SCHMID M BAUERNHOFER T MOSER R PLONER F DERSTVENSCHEG E KASPAREK AK KUSS I WILDERSTRUSCHNIG M LACKNER C STEINDORFER P SAMONIGG H
Citation: H. Stoger et al., A PHASE-II TRIAL OF WEEKLY HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH EPIRUBICIN AS SALVAGE CHEMOTHERAPY IN ADVANCED BREAST-CANCER, Oncology, 51(6), 1994, pp. 518-522
THE PRESENCE OF IMMUNOSUPPRESSIVE P15E-LIKE FACTORS IN THE SERUM AND URINE OF PATIENTS SUFFERING FROM MALIGN AND BENIGN BREAST-TUMORS
Authors: STOGER H WILDERSTRUSCHNIG M SAMONIGG H SCHMID M BAUERNHOFER T TIRAN A TAS M DREXHAGE HA
Citation: H. Stoger et al., THE PRESENCE OF IMMUNOSUPPRESSIVE P15E-LIKE FACTORS IN THE SERUM AND URINE OF PATIENTS SUFFERING FROM MALIGN AND BENIGN BREAST-TUMORS, Clinical and experimental immunology, 93(3), 1993, pp. 437-441
Risultati: 1-10 |